FDA
approval
· 2020-09-21
FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for Rizatriptan Benzoate from Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)